Related Experiment Video

Updated: Aug 11, 2026

Ultrasound-Guided Needle Release Combined with Corticosteroid Injection for the Treatment of Supinator Syndrome
05:18

Ultrasound-Guided Needle Release Combined with Corticosteroid Injection for the Treatment of Supinator Syndrome

Published on: May 26, 2023

[Critical assessment of cortico-steroid therapy of acute thrombopenia (author's transl)]

A M Mingers, J Ströder, G Ebenhöh

    Klinische Padiatrie
    |May 1, 1975
    PubMed

    Insights

    This study analyzed 75 children with thrombocytopenic purpura, finding corticosteroid treatment did not improve acute disease symptoms or hospitalization duration. Findings align with existing literature on pediatric purpura.

    Area of Science:

    • Pediatric Hematology
    • Immunology
    • Clinical Research

    Context:

    • Thrombocytopenic purpura is a significant condition in children.
    • Previous literature provides a baseline for disease characteristics and outcomes.
    • Understanding treatment efficacy is crucial for pediatric care.

    Purpose:

    • To analyze case histories of children hospitalized for thrombocytopenic purpura.
    • To evaluate the influence of corticosteroid therapy on the acute phase of the disease.
    • To compare findings with existing literature on pediatric purpura.

    Summary:

    • Analysis of 75 children (6 months-14 years) with thrombocytopenic purpura.
    • Disease characteristics (sex, age, preceding infections, chronicity, lethality) align with prior reports.
    • Corticosteroids showed no favorable influence on purpura, hemorrhage, platelet quality, organ enlargement, or hospitalization length.

    Impact:

    • Highlights the limited efficacy of corticosteroids in acute pediatric thrombocytopenic purpura.
    • Reinforces the need for further research into effective treatments for this condition.
    • Provides data for clinical decision-making in pediatric hematology.

    Related Concept Videos

    COPD: Management Using Bronchodilators and Corticosteroids01:26

    COPD: Management Using Bronchodilators and Corticosteroids

    Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
    Tissue Transplantation01:24

    Tissue Transplantation

    Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
    The Biology of Tissue Transplantation
    The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
    Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

    Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

    Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
    Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

    Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

    Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
    Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

    Acute Kidney Injury IV: Diagnostic Studies and Prevention

    Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
    Acute Inflammation III: Local and Systemic Effects01:25

    Acute Inflammation III: Local and Systemic Effects

    Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...